Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × NVP-BKM120 × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5 Tumor-Agnostic 3 Head & Neck 2 Genitourinary 2 Gynecologic 1 Gastrointestinal 1 Dermatologic 1

Conditions

Ovarian Neoplasms 4 Endometrial Neoplasms 4 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Colonic Neoplasms 1 Advanced Endometrial Cancer 1

Interventions

pembrolizumab 21 Cyclophosphamide 11 Specimen Handling 9 Paclitaxel 9 Magnetic Resonance Spectroscopy 9 Biopsy 9 Carboplatin 8 fludarabine 7 Doxorubicin 6 aldesleukin 5 Leucovorin 5 Interleukin-2 5 Gemcitabine 5 liposomal doxorubicin 4 Oxaliplatin 4 Nivolumab 4 Irinotecan 4 Fluorouracil 4 Cisplatin 4 fludarabine phosphate 3 dostarlimab 3 avelumab 3 Trastuzumab 3 Topotecan 3 Taxes 3 Fulvestrant 3 Drug Therapy 3 Cetuximab 3 tumor necrosis factor-alpha, CNGRC fusion protein, human 2 spartalizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01397877 2023-09-06

ENDOPIK

ARCAGY/ GINECO GROUP

Phase 2 Completed

Neoplasm Metastasis, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡